According to AMR, the viral vector production market will see tremendous growth, reaching $6.1 billion by 2032

Allied Market Research released a report titled: “Viral vector Pproduction Mmarket by viral vectorType (adenoviral vectors, lentiviral vectors, retrovirals, adeno-associated viral vectors and other viral vectors), by indication (cancer, genetic disorders, infectious diseases and other diseases), by application (gene therapy and vaccinology): Global Opportunity Analysis and Industry Forecast, 2023-2032”. The viral vector production market was valued at $1.1 billion in 2022 and is estimated to reach $6.1 billion by 2032, registering a compound annual growth rate of 18.8% from 2023 to 2032.

• CAGR: 18.8%
• Current market size: $1.1 billion
• Fastest Growing Region: APAC
• Largest market: North America
• Projection period: 2023-2032
• Base year: 2022

Request a sample report:

Our market research solution offers you an answer to the question mentioned below:

• What driving factors are responsible for market growth?
• What are the hurdle factors of this market?
• What new opportunities are emerging that will cause the market to grow in the coming years?
• What are the trends of this market?
• What are the main factors driving new product launches?
• How big is the global and regional market in terms of sales, revenue and production?
• How much will the market grow in terms of sales, revenue and production during the forecast period?
• Which region dominates the global market and what will be the market shares of the individual regions in the overall market in 2022?
• How will each segment grow during the forecast period and how much revenue will these segments account for in 2032?
• Which region has more opportunities?

Key benefits for stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimates and dynamics of the Viral Vector Production market analysis from 2022 to 2032 to identify the prevailing Viral Vector Production market opportunities.
• The market research is offered along with information on key drivers, constraints and opportunities.
• Porter's Five Forces Analysis highlights the potential of buyers and suppliers to empower stakeholders to make profitable business decisions and strengthen their supplier-buyer network.
• An in-depth analysis of viral vector production market segmentation helps identify the prevailing market opportunities.
• The most important countries in each region are mapped according to their sales contribution to the global market.
• The positioning of market participants facilitates benchmarking and ensures a clear understanding of the current position of market participants.
• The report covers the analysis of regional and global viral vector production market trends, key players, market segments, application areas and market growth strategies.

For purchase inquiries –

North America to maintain its dominance until 2032

In 2022, North America had the largest share of revenue in the viral vector production sector, accounting for over two-fifths of the global market. This dominance is expected to continue throughout the forecast period, owing to the region's robust healthcare infrastructure and significant prevalence of cancer and genetic disorders.

Meanwhile, Asia Pacific is expected to record the fastest compound annual growth rate (CAGR) of 19.8% from 2023 to 2032. This growth trajectory is driven by the sizable population in countries such as China and India, increasing healthcare spending, evolving healthcare infrastructure, and increasing awareness of gene therapy among the population.

Key results of the study

• Based on viral vector type, the adeno-associated viral (AAV) vectors segment was the largest contributor to the market in 2022 and the lentiviral vectors segment is expected to drive the market during the forecast period.
• According to the indications, the cancer segment dominated the market in 2022 and the genetic disorders segment is expected to grow fastest during the forecast period for the viral vector production market.
• Based on application, the gene therapy segment led the market in 2022; and is expected to grow at the highest CAGR during the forecast period.
• Regionally, North America generated the largest revenue in the viral vector production industry in 2022. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period.

Leading Market Players:-

• Andelyn Life Sciences
• Charles River Laboratories
• Danaher Corporation
• FinVector Oy
• Lonza
• Novartis AG
• Oxford Biomedica plc
• Takara Holdings Inc.
• Thermo Fisher Scientific Inc.
• Avid Bioservices Inc.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐨𝐩 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧 –

External Urine Management Products Market

Tumor ablation market

About Us
Allied Market Research (AMR) is a market research and business consulting firm of Allied Analytics LLP based in Portland, Oregon. AMR provides market research reports, business solutions, consulting services and market insights across 11 industries. By using comprehensive research methodologies, AMR is instrumental in helping its clients make strategic business decisions and achieve sustainable growth in their market areas. We have qualified analysts and experts and have extensive experience working with many Fortune 500 companies and small and medium-sized businesses.

Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
International: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
[email protected]
Web: www.alliedmarketresearch.com
Allied Market Research Blog: